Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNA interference (RNAi) therapeutics company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of its RNAi therapeutic vutrisiran for the treatment of wild type or hereditary transthyretin amyloidosis in adult patients with cardiomyopathy (ATTR-CM). ATTR-CM is a debilitating, rapidly progressive and potentially fatal ...

HistoSonics, the developer of the Edison Histotripsy System, announced today 12-month follow-up clinical data from its prospective #HOPE4LIVER trials, designed to evaluate the safety and efficacy of histotripsy for the non-invasive destruction of primary (hepatocellular cancer-HCC) and metastatic liver tumors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250428931117/en/ The Edison System, which received U.S. Food and Drug Administ...

Kao Corporation (TOKYO:4452) has identified its international makeup brand KATE as a strategic growth driver within its cosmetics portfolio. This initiative aligns with the company’s ambition to establish a “Global Sharp Top” business framework. In line with this vision, Kao is making significant investments to amplify KATE’s global presence. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250603453681/e...

Jacek Olczak, Chief Executive Officer of Philip Morris International Inc. (NYSE: PM), outlined the need for common-sense regulations in the consumer goods sector while addressing global leaders at Semafor’s annual World Economy Summit in Washington, D.C., on April 25, 2025. Olczak emphasized the sector’s potential for innovation-led growth despite the volatile economic environment. He stressed, however, that without appropriate regulation and policy frameworks to enable scientific evaluation an...

Headline of release issued April 22, 2025, at 9:30 p.m. PT/April 23, 2025, at 12:30 a.m. ET should read: Saviynt Hires Identity Veteran Roger Hsu to Accelerate Asia Growth (instead of Saviynt Hires Former SailPoint ASEAN Leader Roger Hsu to Accelerate Asia Growth). The updated release reads: SAVIYNT HIRES IDENTITY VETERAN ROGER HSU TO ACCELERATE ASIA GROWTH Appointment of cybersecurity veteran underscores Saviynt’s commitment to identity security amid rising threats and rapid growth across A...

Mainstay Medical Holdings plc today announced that Anthem Blue Cross and Blue Shield (“Anthem”) has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for the treatment of intractable chronic low back pain. ReActiv8 is the only therapy considered medically necessary by the policy when the conditions for coverage are met. The coverage went into effect on April 16, 2025, and expands access to the procedure, when clinically appropriate, to Anthem’s pol...